期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Values of medical-grade smart wearable device onimprovement of individual healthTaking philips health watch as an example
1
作者 Oscar Wager Fong 《中西医结合护理(中英文)》 2016年第10期1-5,共5页
Health is an inevitable demand to promote people's all-round development and to make foundation for economic and social development. Health and longevity of citizens is not only important symbols of national devel... Health is an inevitable demand to promote people's all-round development and to make foundation for economic and social development. Health and longevity of citizens is not only important symbols of national development and prosperity but also the common wish of the Chinese people. Actually,smart wearable technology is an emerging one and the application of some smart wearable devices such as health watch is the most promising one in the health industry. As new psychotherapy,cognitive behavioral therapy( CBT) can change the poor awareness by means of changing one's way of thinking,thus eliminating the unhealthy emotions and behaviors. In terms of health management,CBT enjoys such advantages as guidance,motivation,integrity and short therapy time. This paper introduces the improvement of smart wearable device guided by professional health management solutions on individual health by taking Philips health watch as an example,and the users can therefrom get full understanding of the relationship between smart wearable devices and health,thus improving their individual health. 展开更多
关键词 medical GRADE smart WEARABLE device INDIVIDUAL HEALTH PHILIPS HEALTH WATCH be-havior lifestyle
下载PDF
Diagnosis and Treatment Guidelines for Mesenchymal Stem Cell Therapy for Coronavirus Disease 2019(Beijing,2021)
2
作者 Ruonan Xu Lei Shi +28 位作者 Wei-Fen Xie Zhe Xu Fan-Ping Meng Jun-Liang Fu Xin Yuan Lei Huang Ming Shi Yonggang Li Yuanyuan Li Chen Yao Yu Zhang Zhongmin Liu Chenyan Gao Zhaohui Wu Shufang Meng Weidong Han Charlie Xiang Gui-Qiang Wang Taisheng Li Xiaoying Wang Yunxia Sun Zunyou Wu Wenhong Zhang Chunhua Zhao Yu Hu Tao Cheng Yuquan Wei Qi Zhou Fu-Sheng Wang 《Infectious Diseases & Immunity》 2021年第2期68-73,共6页
The coronavirus disease 2019(COVID-19)can be caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection,and has led to millions of deaths among more than 100 million infected people around the worl... The coronavirus disease 2019(COVID-19)can be caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection,and has led to millions of deaths among more than 100 million infected people around the world according to the declaration from World Health Organization.Dysregulated immune response of both the innate and adaptive immune systems is subsistent on COVID-19 patients,of which the degree are associated with disease severity,lung damage and long term functional disability.Current treatment options have included antiretroviral drugs,anti-inflammatory factors,antibodies,immune checkpoint inhibitors,and convalescent plasma therapy.More recently,mesenchymal stem cell(MSC)therapy has been explored for the management and control of COVID-19,particularly with the aim of preventing or at least mitigating respiratory co-morbidities.Though the safety and efficacy of stem cell therapy have been validated in multiple phase I–III clinical trials,to date,no standardized stem cell preparation,administration dosage or interval,product QA/QC testing,storage,transportation,or disposal protocols have been established.The present paper proposes a systematic methodology that addresses all the foregoing process steps and evaluation criteria for the efficacious and safe administration of MSCs in the treatment of patients infected with COVID-19. 展开更多
关键词 COVID-19 Mesenchymal stem cell TREATMENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部